BOBahar Ormen

Bahar Ormen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bahar Ormen has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discriminative Role of Interleukin-6, Neuropilin-1, and Amphiregulin for Cirrhosis in Patients with Chronic Hepatitis B Infection

    by Fatma Karakoc Ozudogru, Banu Karaca, Nesrin Turker, Bahar Ormen, Sezgin Vatansever, Huriye Erbak Yılmaz, Furkan Oguzhan Karalar, Fulya Gunsar, Alper Sener

    Background/Aims: The roles of inflammatory and fibrogenic biomarkers in chronic hepatitis B (CHB) infection and hepatitis B virüs (HBV)-related cirrhosis remain incompletely understood. The current study investigated the diagnostic and discriminative ability of amphiregulin (AREG), interleukin-6 (IL-6), and neuropilin-1 (Nrp-1) as biomarkers of HBV-related cirrhosis. Materials and Methods: This cross-sectional analytical study included 70 patients with CHB (43 without cirrhosis and 27 with HBVrelated cirrhosis) and 60 healthy controls. Clinical and laboratory data were obtained from hospital records. Serum IL-6, Nrp-1, and AREG levels collected during outpatient visits were measured using enzyme-linked immunosorbent assay. Group differences were analyzed using the Kruskal–Wallis test, discriminative performance was evaluated using receiver operating characteristic (ROC) analysis, and factors independently associated with cirrhosis were identified using logistic regression. Results: IL-6 and Nrp-1 levels were higher in patients with noncirrhotic and HBV-related cirrhotic CHB than in healthy controls (P < .001), with no significant difference between the patient subgroups. AREG levels were lower in the overall CHB cohort than in controls (P < .001) but higher in patients with cirrhosis than in those without cirrhosis (P = .001). ROC analysis showed that AREG had moderate discriminative ability for HBV-related cirrhosis (area under the curve (AUC) = 0.749). The optimal Youden-derived cutoff value was 2.29 ng/mL, with a sensitivity of 74% and a specificity of 65%. In logistic regression, AREG was independently associated with HBV-related cirrhosis (P = .012). Addition of ln-transformed AREG to age- and sex-adjusted aspartate aminotransferase-to-platelet ratio index (APRI)- and Fibrosis-4 index (FIB-4)-based models increased the AUC from 0.923 to 0.970 and from 0.938 to 0.980, respectively. Conclusion: AREG may serve as a complementary biomarker with moderate discriminative value for HBV-related cirrhosis but is unlikely to be useful as a standalone diagnostic or prognostic marker. Although IL-6 and Nrp-1 reflected underlying inflammatory activity, their ability to distinguish cirrhosis was limited. Cite this article as: Karakoc Ozudogru F, Karaca B, Turker N, et al. Discriminative role of interleukin-6, neuropilin-1, and amphiregulin for cirrhosis in patients with chronic hepatitis B infection. Turk J Gastroenterol. Published online July 9 2026. doi:10.5152/tjg.2026.26143.

  • Open Access

    Predictors of mortality in post-neurosurgical Gram-negative bacterial meningitis: a five-year retrospective study

    by Bahar Ormen, Hasan K Sucu, Cansu Aksoy Aksit, Banu Karaca, Nesrin Turker, Ismail E Sevin

    Introduction: The incidence of Gram-negative bacterial meningitis (GNBM) has increased with the growing number of neurosurgical procedures. Concurrently, global antimicrobial resistance, particularly among Gram-negative pathogens causing healthcare-associated infections, has contributed to high morbidity and mortality. This study aimed to identify clinical and laboratory parameters associated with mortality in post-neurosurgical GNBM (PN-GNBM). Methodology: This retrospective study included adult patients who developed GNBM at least 48 hours after a neurosurgical procedure in the intensive care unit of a tertiary hospital between January 2019 and March 2024. Clinical findings and laboratory results before and at the time of diagnosis were obtained from the hospital information system. The factors associated with all-cause 28-day mortality were evaluated. Statistical analyses were performed using SPSS version 19, with p < 0.05 considered statistically significant. Results: A total of 21 PN-GNBM patients were included. The 28-day mortality rate was 60%. Evaluation of peripheral blood leukocyte ratios at the time of diagnosis revealed that a low lymphocyte-to-platelet ratio (LPR) significantly predicted mortality on days 7, 14, and 21 (p = 0.046, 0.003, and 0.005, respectively), whereas a high neutrophil-to-lymphocyte ratio (NLR) predicted 14-day mortality (p = 0.035). Acinetobacter baumannii was the most frequently isolated pathogen with 81.81% carbapenem resistance rate. Conclusions: NLR and LPR are inexpensive and readily accessible biomarkers that may support early mortality prediction and risk stratification in PN-GNBM. These preliminary findings should be validated in larger multicenter studies.

  • How Successful are We in the Elimination of HCV Infection in the Alcohol and Substance-Dependent Population?

    by Nesrin Türker, Banu Karaca, Hatice Burcu Açikalin Arikan, Bahar Örmen, Figen Kaptan, Başak BAĞCI, Özge Eren Korkmaz

  • Open Access

    A COVID-19 Case with Cerebral Sinus Vein Thrombosis

    by Bahar Örmen, Nesrin Türker, Banu Karaca, İsmail Ertan Sevin, Ramazan Özdemir, Figen Kaptan, Nurbanu Sezak, Bilal Olcay Peker

    The risk of thromboembolic pathologies increases in COVID-19 cases who have risk factors for poor prognosis and are prone to have a severe clinical course. Few cases of cerebral sinus vein thrombosis (CSVT) accompanying COVID-19 have been reported. We present a patient who developed CSVT during COVID-19 without a known risk factor for thrombosis but was found to have a genetic mutation of the prothrombin 20210 G/A gene, which is a congenital thrombophilia risk factor. We aim to emphasize the importance of investigating additional pathologies in thromboembolic events during COVID-19 in cases without known comorbidities.

  • Open Access

    Management of Chronic Hepatitis C Virus Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update

    by Bilgehan Aygen, Yunus Gurbuz, Rıza Aytaç Cetinkaya, Gule Cınar, Uner Kayabas, Bahar Ormen, Pınar Korkmaz, Emine Turkoglu-Yilmaz, Nese Demirturk

    Direct-acting antiviral (DAA) drugs have increased the effectiveness of treatment in hepatitis C patients. With the developments in the world and DAA drugs coming into use in our country, the consensus report on the management of hepatitis C virus (HCV) infection has needed to be updated. It was first published in 2014 and updated in 2017 by the Viral Hepatitis Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases. Here, the Study Group has reviewed every aspect of chronic hepatitis C and revised the consensus report with the updated information. At the end of each topic, the agreed recommendations are summarized, considering the drugs reimbursed in our country.


  • Evaluation of Cardiovascular Risks and Dyslipidemia in HIV-positive Patients

    by Banu Karaca, Fahrettin Tuğrul Çitekçi, Beyza Erol, Bahar Örmen, Nurbanu Sezak, Figen Kaptan, Tuncay Kırış


  • Toplum Kökenli Santral Sinir Sistemi Enfeksiyonlarında Bakteriyel ve Viral Etiyolojinin Moleküler Yöntemlerle Değerlendirilmesi

    by Hasip Kahraman, Alper Tünger, Şebnem Şenol, Hörü Gazi, Meltem Avci, Bahar Örmen, Nesrin Türker, Sabri Atalay, Şükran Köse, Sercan Ulusoy, et al.

    In this multicenter prospective cohort study, it was aimed to evaluate the bacterial and viral etiology in community-acquired central nervous system infections by standart bacteriological culture and multiplex polymerase chain reaction (PCR) methods. Patients hospitalized with central nervous system infections between April 2012 and February 2014 were enrolled in the study. Demographic and clinical information of the patients were collected prospectively. Cerebrospinal fluid (CSF) samples of the patients were examined by standart bacteriological culture methods, bacterial multiplex PCR (Seeplex meningitis-B ACE Detection (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, Listeria monocytogenes, Group B streptococci) and viral multiplex PCR (Seeplex meningitis-V1 ACE Detection kits herpes simplex virus-1 (HSV1), herpes simplex virus-2 (HSV2), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein Barr virus (EBV) and human herpes virus 6 (HHV6)) (Seeplex meningitis-V2 ACE Detection kit (enteroviruses)). Patients were classified as purulent meningitis, aseptic meningitis and encephalitis according to their clinical, CSF (leukocyte level, predominant cell type, protein and glucose (blood/CSF) levels) and cranial imaging results. Patients who were infected with a pathogen other than the detection of the kit or diagnosed as chronic meningitis and other diseases during the follow up, were excluded from the study. A total of 79 patients (28 female, 51 male, aged 42.1 ± 18.5) fulfilled the study inclusion criteria. A total of 46 patients were classified in purulent meningitis group whereas 33 were in aseptic meningitis/encephalitis group. Pathogens were detected by multiplex PCR in 41 patients. CSF cultures were positive in 10 (21.7%) patients (nine S.pneumoniae, one H.influenzae) and PCR were positive for 27 (58.6%) patients in purulent meningitis group. In this group one type of bacteria were detected in 18 patients (14 S.pneumoniae, two N.meningitidis, one H.influenzae, one L.monocytogenes). Besides, it is noteworthy that multiple pathogens were detected such as bacteria-virus combination in eight patients and two different bacteria in one patient. In the aseptic meningitis/encephalitis group, pathogens were detected in 14 out of 33 patients; single type of viruses in 11 patients (seven enterovirus, two HSV1, one HSV2, one VZV) and two different viruses were determined in three patients. These data suggest that multiplex PCR methods may increase the isolation rate of pathogens in central nervous system infections. Existence of mixed pathogen growth is remarkable in our study. Further studies are needed for the clinical relevance of this result.


  • Evaluation of Clinical and Laboratory Findings of Adult Visceral Leishmaniasis Cases

    by Serap Ural, Figen Kaptan, Nurbanu Sezak, Sibel EL, Bahar Örmen, Nesrin Türker, Tuna Demi̇rdal, İlknur Vardar, Pınar Özkan Çayiröz, Fulya Çakalağaoğlu

    Visceral leishmaniasis (VL, kala-azar) is a zoonotic infection caused by Leishmania species which are transmitted to humans by the bites of infected female phlebotomine sandflies. Leishmania infantum is the responsible species of VL in Aegean, Mediterranean, and Central Anatolia regions of Turkey mainly observed sporadically in pediatric age groups. The aim of this study was to evaluate the clinical and laboratory findings of adult patients with VL who were admitted to our hospital. A total of 10 patients (3 female, 7 male; age range: 18-67 years, mean age: 39.3 ± 16.51) followed in the infectious diseases clinic of the hospital between 2000 and 2013 were evaluated retrospectively. The diagnosis of VL was based on the presence of appropriate clinical and physical examination, as well as biochemical findings, positive serological test results (indirect fluorescent antibody test, and rK39 rapid antigen test) and/or detection of amastigote forms of parasite in the bone marrow aspiration samples. Of the cases three were diagnosed with both bone marrow and serology positivity, five with bone marrow positivity and one of each only with liver biopsy and positive serology result. Time interval from onset of the symptoms until the establishment of the specific clinical diagnosis was ranged from 2 to 12 weeks. The most frequent initial symptoms were fever, fatigue and abdominal distension. None of the patients had immunosupressive conditions such as HIV infection, corticosteroid use, immunosupressive treatment, or transplantation. All the patients were from Aegean region and six were living in rural areas. In all cases, hepatosplenomegaly, increased erythrocyte sedimentation rate, albumin/globulin ratio inversion, anemia, leukopenia and among nine cases trombocytopenia were detected. In one case acute renal failure has been developed before treatment and the patient was admitted to dialysis program. Bacterial superinfection occurred in two cases. Patients were treated with either meglumine antimonate (Glucantime(®), 20 mg/kg/day, intramuscularly for 28 days) or liposomal amphotericin B (3 mg/kg/day, intravenously for the first 5 days, then on 14(th) and 21(st) days) according to the availability of drugs. During one year follow-up period all of the patients improved and no recurrence was seen in any patient. In conclusion, among adult patients with fever uncontrolled within 2-week course of ampiric antibiotic treatment without any infectious focus or malignancy, VL should also be considered.